50% off Premium Yearly

TSE:SIS
This summary was created by AI, based on 5 opinions in the last 12 months.
Savaria Corp (SIS-T) has garnered positive reviews from various experts, highlighting its resilience and potential for growth despite challenges such as tariffs. Analysts note that the company has shifted its focus towards Europe and is benefitting from trends in the accessibility industry, aimed at serving an aging population that prefers aging in place. The stock experienced fluctuations but has shown a strong recovery, with products that are compliant with CUSMA and many being FDA-regulated, making them less susceptible to tariffs. With an emphasis on cost-cutting and innovative product development, Savaria appears well-positioned for continued growth. Currently, it offers a yield of 2.69% and has an analysts’ price target of $24.44, suggesting a favorable outlook for potential investors.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The Handicare acquisition is very big and will increase revenues by 50%. 5i likes the deal and believes there will be additional synergie over time. The deal is set to increase geographic reach and customer base. The financing may cause short term volatility but EBITDA was better than expected and sales were just below estimates. Unlock Premium - Try 5i Free